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Background: In order to become functionally competent but harmless mediators of the immune system, T cells
undergo a strict educational program in the thymus, where they learn to discriminate between self and non-self.
This educational program is, to a large extent, mediated by medullary thymic epithelial cells that have a unique
capacity to express, and subsequently present, a large fraction of body antigens. While the scope of promiscuously
expressed genes by medullary thymic epithelial cells is well-established, relatively little is known about the
expression of variants that are generated by co-transcriptional and post-transcriptional processes.
Results: Our study reveals that in comparison to other cell types, medullary thymic epithelial cells display
significantly higher levels of alternative splicing, as well as A-to-I and C-to-U RNA editing, which thereby further
expand the diversity of their self-antigen repertoire. Interestingly, Aire, the key mediator of promiscuous gene
expression in these cells, plays a limited role in the regulation of these transcriptional processes.
Conclusions: Our results highlight RNA processing as another layer by which the immune system assures a
comprehensive self-representation in the thymus which is required for the establishment of self-tolerance and
prevention of autoimmunity.
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Self-toleranceBackground
Central tolerance is established in the thymus, where
immature T lymphocytes are instructed by thymic
stroma to become immunocompetent cells capable of
recognizing foreign invaders while tolerating the body’s
own components. This process is primarily mediated by
both negative selection of potentially self-reactive T cell
clones and the induction of CD25+, Foxp3+ T regulatory
(Treg) cells by various thymus-resident antigen-presenting
cells [1]. In particular, medullary thymic epithelial cells
(mTECs) were shown to play the main role in this process,
because of their unique ability to promiscuously express
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(http://creativecommons.org/publicdomain/zeself-antigens, including those that normally have high tis-
sue restriction [2]. The expression of transcripts encoding
many of these tissue-restricted antigens (TRAs) is regu-
lated by a single transcriptional regulator: the autoimmune
regulator Aire [3]. Indeed, mice with a dysfunctional Aire
gene express only a fraction of the TRA repertoire and as
a result develop autoantibodies and immune infiltrates
directed at multiple peripheral tissues [3]. Similarly, hu-
man patients with dysfunctional AIRE gene suffer from a
devastating Autoimmune polyendocrine syndrome type 1
(APS1) [4, 5].
RNA-processing mechanisms, in particular alternative
splicing (AS) and RNA editing, enable the production of
multiple mRNA transcripts from the same gene, thereby
expanding the diversity and complexity of individual
gene products. Consequently, a single gene may give rise
to different protein variants with different functional
roles in different tissues [6, 7]. Current estimates suggest
that ~95 % of genes with more than one exon undergole is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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thousands of different isoforms [10]. In many cases, AS
preserves the protein open reading frame, leading to the
expression of different protein isoforms, which fre-
quently have different functional properties [11, 12]. A
common consequence of AS in metazoans is insertion
or deletion of entire segments of a protein as a result of
an in-frame cassette exon insertion or exclusion [13].
Transcript and protein diversities are further increased
by various RNA-editing mechanisms, which induce single
nucleotide substitution in the RNA, which may thereby
alter the protein sequence and function. In mammals,
RNA editing involves mainly deamination of adenosine
(A) to inosine (I) (recognized as guanosine (G) by all mo-
lecular machineries) mediated by the adenosine deami-
nases acting on RNA (ADARs) protein family [14, 15].
These enzymes have a large number of targets in both hu-
man and mice and frequently edit several sites in clusters
and may lead to changes in several amino acids in a single
protein [16–20]. It is also noteworthy that ADAR activity
was first isolated from a calf thymus [21]. Another, less
prevalent, type of RNA editing involves deamination of
cytosine (C) to uridine (U) by the APOBEC protein family
of cytidine deaminases, mainly Apobec-1 [22, 23]. Until
recently, the only gene reported to undergo codon alter-
ation caused by C-to-U editing was Apolipoprotein B
(ApoB) [24, 25]. Interestingly, ApoB is an Aire-dependent
tissue-restricted antigen, whose expression is mainly re-
stricted to the small intestine and liver. More recently,
additional transcripts were shown to undergo C-to-U edit-
ing in their coding sites by Apobec3A in humans [26], or
by Apobec1 within their 3' UTRs in mice [27, 28].
RNA processing in the peripheral tissues may increase
the repertoire of potentially immunogenic epitopes,
which may then be recognized as non-self-peptides by
the adaptive immune system. This is particularly true for
any protein variant, which was not presented to the de-
veloping T cells in the thymus [29]. For instance, a splice
variant of mouse PLP gene was shown to be expressed
in oligodendrocites, but not in the thymus, suggesting
that absence of the specific exon in the thymus may re-
sult in loss of tolerance to the relevant polypeptide in
the periphery [30].
Here, we evaluate the extent of various co-transcriptional
and/or post-transcriptional RNA process products expressed
in mTECs, assess the intrinsic diversity of the individual
self-antigen transcripts, and compare it with that of other
cell types and tissues. To this end, we analyzed available
RNA-sequencing (RNA-seq) datasets and determined the
extent and diversity of gene expression, AS and RNA edit-
ing in mTECs in comparison with other tissues and cell
types in the body. Indeed, our analyses demonstrate that,
on average, mTECs express 3000–6000 more genes than
other tissues. Interestingly, the extent of representation ofthe individual tissues within mTECs is very diverse,
ranging from relatively low (e.g. testis or brain) to high
(e.g. colon or skin) levels of tissue-specific coverage.
Moreover, our results reveal that mTECs display a rela-
tively high level of AS and RNA editing, which thus
helps to further expand the already broad repertoire of
self-antigens in the thymus. Our results therefore high-
light yet another level by which the immune system
assures a comprehensive representation of the body’s
own proteins in the thymus.
Results
Medullary thymic epithelial cells express ~85 % of the
entire coding genome
Although promiscuous gene expression in mTECs is a
well-established biological phenomenon [31], the extent
of such expression, especially in comparison with other
tissues, has not yet been analyzed in a comprehensive
manner using state-of-the-art methodologies. Therefore,
to better determine the fraction of genes expressed in
mTECs and other mouse tissues, we took advantage of
RNA-seq technology. Specifically, we performed a com-
parative analysis of RNA-seq datasets obtained from differ-
ent mTECs populations as well as ten different tissues and
epithelial cell populations, including brain, testes, liver,
kidney, lung, colon, skeletal muscle (skm), spleen, cortical
thymic epithelial cells (cTECs), and skin epithelial cells
(skinEC) [32, 33]. The mTEC populations included: (1)
MHC-II low mTECs (mTEClo), which mainly represent
an immature mTEC population; (2) MHC-II high
mTECs (mTEChi), mainly representing a mature popu-
lation; and (3) an Aire-deficient mTEChi population
(AireKO), which is severely impaired in promiscuous
gene expression (see “Methods”).
The analysis, using the selected cutoff (see “Methods”),
revealed that most of the tissues express 12,000–14,000
genes (i.e. 60–65 % of the coding genome) (Fig. 1a). The
lung and two immunologically privileged sites, brain and
testis, were the only tissues that expressed a larger frac-
tion of the genome, in the range of 70–75 %. This was
not entirely surprising, as enhanced global gene expres-
sion in the brain and testis has been reported in the past
by several independent studies [34–37]. In line with
other recently published studies, the mTEChi population
expressed nearly 18,000 genes, which represents ~85 % of
the coding genome, while Aire-deficient mTECs (AireKO)
expressed approximately 15,000 genes, suggesting that
Aire is responsible for the induction of ~3000 genes in
mTECs [38–40]. Interestingly, even in the absence of
Aire, the mTECs expressed a relatively large fraction of
the genome (~75 %), considerably exceeding the overall
genome expression in other peripheral tissues (Fig. 1a).
Interestingly, neither cTECs nor skinEC demonstrated
higher overall genome expression than other tissues,
Fig. 1 mTECs express higher number of genes compare to other tissues. a Mature mTECs expressed higher number of genes than all the tissues
and cell types examined, including the brain and testes. Number of protein-coding genes expressed (at least 0.01 reads/nt) in eight different
tissue types (brain, testes, colon, kidney, liver, lung, skeletal muscle (skm), and spleen), two epithelial cell types: cortical thymic epithelial cells
(cTECs) and skin epithelial cells (skinEC), and three types of mTECs (low MHC-II [mTEClo], high MHC-II [mTEChi], and Aire-deficient [AireKO]) on the
basis of 10–60 million randomly selected aligned RNA-seq reads for each sample. Gray lines denote the percentage of genes out of 21,111
accounted in this analysis. b Distribution of gene expression levels of immature mTECs exhibit a high ratio of lowly expressed genes and is
different from other tissues and cell types examined. Kernel density estimates of normalized read counts distributions of 50 million randomly
selected aligned reads from the same RNA-seq data within protein-coding genes. Vertical line denotes the expression detection threshold used
in Fig. 1a (0.01 reads/nt)
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unique to the mTECs population (Fig. 1). Notably, the
mTEClo population was also characterized by a strong
promiscuous gene expression. However, the levels of many
individual transcripts were dramatically lower than in the
mTEChi population as clearly illustrated in Fig. 1b.
Differential projection of tissues’ self-shadows in mTECs
Although mTECs are characterized by a very high level of
promiscuous expression of TRA genes (Fig. 1), whether
mTECs mirror all peripheral tissues to the same extent
has not yet been thoroughly analyzed. To better address
this question, we analyzed the level of overlap of tissue-
restricted genes for each individual tissue (or cell type) by
performing leave-one-out analysis and TRA detection on
all RNA-seq datasets. For this analysis, a TRA gene was
defined as a gene that was highly expressed (FragmentsPer Kilobase of transcript per Million mapped reads
(FPKM) > 5) in one of the tissues examined and was either
lowly (FPKM< 0.3) or not expressed in the other analyzed
tissues (except mTECs).
As expected, most of the analyzed peripheral tissues
were, to a large extent, mirrored in the mTEChi popula-
tion (Fig. 2a), which expressed ~60–100 % of their tissue-
specific gene signature. In contrast, the brain and testes
demonstrated a relatively small overlap of their specific
TRA gene signatures with the mTEChi population. Spe-
cifically, mTECs expressed only 31 % of testis-specific
and 55 % of brain-specific antigens (Fig. 2a), indicating
that many genes specific to these two immunologically
privileged tissues are not mirrored on the “central level”
by mTECs.
The overlap between mTECs and other tissues dramat-
ically decreased to 14–67 % in the Aire-deficient mTEChi
Fig. 2 mTEC cells express higher percentage of tissue specific genes compare to any other tissue. a Percentage of the tissue restricted antigens
(TRA) genes of each tissue expressed in mature mTECs (mTEChi) and Aire-deficient (AireKO) cells. The number of TRA genes expressed in the
tissue is indicated in parentheses. A relatively low fraction of TRA genes of testes and brain are expressed in mTECs. b Leave-one-out analysis
comparing TRA expression across all tissues. The percentage of the coding genes uniquely expressed in both tissue 1 and tissue 2 (and not in
other tissue examined) out of the genes expressed only in tissue 1 (and not in other tissue except tissue 2) are presented. The ratio of expressed
TRA is the highest in mTECs compare to other tissues. cTEC cortical thymic epithelial cells, skinEC skin epithelial cells, skm skeletal muscle
Danan-Gotthold et al. Genome Biology  (2016) 17:219 Page 4 of 13population (Fig. 2a). Importantly, leave-one-out analysis
with different parameters (see “Methods”), in which we
removed one sample for the TRA detection step and then
detected the ratio of TRAs of each of the other samples
expressed in the removed sample, further supported
these results and also demonstrated that other tissues
have dramatically lower TRA overlap between them-
selves (3–48 %), with a mean percentage lower than
15 % (Fig. 2b and Additional file 1: Figure S1).
mTECs are characterized by a high number of AS events
per gene
As discussed above, AS of a single gene can give rise to
several different protein variants, which differ in their
amino acid sequences [10]. This phenomenon further
increases the diversity of self-antigens in specific tissuesand/or different developmental stages and creates an
additional challenge for the immune system to avoid
self-reactivity [10, 41]. Therefore, to better assess the de-
gree of AS in mTECs and in other cell types and tissues,
we counted the number of splice junctions detected for
each coding gene in the RNA-seq datasets that were
available to us. In order to have a comparable and uni-
form set of reads from each of the various samples, we
randomly selected 50 million reads from each sample
and trimmed long reads to 80 nucleotides.
We first compared the fraction of alternatively spliced
genes out of all expressed coding genes that have mul-
tiple exons in each sample. We excluded mTEClo cells
from this type of analysis due to their high ratio of lowly
expressed genes and abnormal gene expression pattern
(Fig. 1b), which could therefore influence the results for
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all analyzed cell types and tissues, mature mTECs
express the highest fraction of alternatively spliced
protein-coding genes, independently of their expression
levels (Fig. 3a). The higher ratio of alternatively spliced
genes in the lower quintile group may indicate that the
concentration of each splice variant in these cells is rela-
tively uniform. This is in line with previously reported
data demonstrating that mTECs display high splicing
entropy [42].
Next, we examined the number of splice junctions de-
tected in each gene in mTECs versus other tissues. For
most of the genes, mTECs expressed either equal or
higher numbers of splice junctions (Fig. 3b). This was also
observed in the testes and brain, which were previously
shown to have complex AS patterns [34, 43]. Similar
results were obtained when analyzing only moderately
expressed genes (FPKM< 2, Additional file 1: Figure S2),Fig. 3 High level of AS in mTECs compared to other tissues. a Mature mTE
alternatively spliced genes detected in each tissue in four levels of gene ex
splice junctions per gene compare to other tissues. Dot plot of splice junct
(mTEChi) and each sample examined. Red dots denote a difference of more
splice junctions difference per gene. Axes were limited between 0–100 spli
brain and spleen. Reads coverage of mutually exclusive exons in each tissu
expressed in mature mTECs and AireKO samples. Fraction of tissue restricte
AireKO sample. Asterisk denotes a statistically significant change between mdemonstrating that the complex splicing pattern is not a
result of high expression level of these genes in mTECs.
Moreover, Multivariate Analysis of Transcript Splicing
(rMATS) [44] also demonstrated that mTECs express
more splice variants compared to other tissues except for
the brain (Additional file 1: Table S2). A good example is
the Src tyrosine kinase Fyn, which is highly expressed in
the hematopoietic system and in the brain. As can be seen
in Fig. 3c, it exists in two major alternatively spliced forms,
which are either hematopoietic-specific or brain-specific
[45]. Importantly, both alternative forms were found in
mTECs in relatively equal levels, suggesting that mTECs
cover various tissue-specific splice variants of the same
gene in relatively equal distribution.
In addition, we also examined the level of tissue-
restricted splice junctions, which are uniquely found only
in one, but not in the other tissues, whereas the gene was
expressed in other tissues. The rate of tissue-restrictedCs express the highest rate of alternatively spliced genes. A fraction of
pression (by quartiles). b Mature mTECs express a higher number of
ions number detected for each gene expressed in both mature mTECs
than five splice junctions per gene, gray dots denote five and fewer
ce junctions per gene. c Fyn alternative splicing pattern in mTECs,
e is presented. d Similar rate of tissue restricted spliced junctions is
d spliced junctions (TRA junctions) expressed in mature mTECs and
TEChi and AireKO sample (p value≤ 0.05)
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to tissue, with relatively high rates for the colon or lung to
lower relative rates for the skin or skeletal muscle (Fig. 3d).
Overall, the fraction of tissue-restricted splice junctions
covered by mTECs was lower than the whole gene TRA
coverage for all tissues, indicating splicing isoforms
representation by mTECs is less comprehensive. These
results were consistent also when using different num-
ber of randomly selected reads from the mTEChi sam-
ple (Additional file 1: Figure S3). Moreover, we also
examined the levels of tissue-restricted splice junctions
with pre-known AS events that are annotated in the
UCSC database (Alt Events track) [46]. Indeed, this
analysis further demonstrated that mTECs express high
rates of tissue-restricted splice junctions of most of the
tissues examined (Additional file 1: Figure S4).
Surprisingly, in contrast to the previously published
study [42], the extent of representation of splice isoforms
was comparable between the wild type (WT) and the Aire-
deficient mTECs for most of the tissue-specific transcripts
(Fig. 3d), suggesting that the high level of AS in mTECs is,
to a large extent, Aire-independent. The only exceptions
were kidney-specific and testis-specific transcripts, which
showed a reduced rate of splice junctions in Aire-deficient
mTECs (Fig. 3d). Similar results were obtained when only
genes with high expression level were included in the
analysis (FPKM> 2, Additional file 1: Figure S5).
mTEC cells are characterized by high RNA-editing rate
In addition to AS, protein diversity is further expanded
by RNA editing, which can make discrete changes to
specific nucleotide sequences within an RNA molecule
after it has been generated by RNA polymerase [47].
Two types of RNA mammalian nucleobase modifications
are known, adenosine (A) to inosine (I) and cytidine (C)
to uridine (U) deaminations. These editing reactions are
mediated by two RNA-editing families of enzymes, Adar
and Apobec, respectively [14, 48]. Although most A-to-I
RNA-editing events are taking place within non-coding
regions of the genome, editing in coding genes may
cause a non-synonymous change at the protein level. In
order to assess the extent and distribution of A-to-I
RNA editing with an effect at the proteome level, we
examined the editing frequency of all editing sites in the
RADAR database [18] in addition to sites obtained from
the hyper-editing analysis (see below) with a non-
synonymous effect on the derived protein (i.e. 50 unique
sites in total, edited (supported by at least five reads) in
one or more of the tissues examined) (Fig. 4a). Out of
29 sites covered by at least ten reads in mTEChi sample,
19 sites (i.e. 65.5 %) were found to undergo RNA editing.
In the vast majority of these recoding edited sites in
mTECs (73.7 %), RNA-editing levels were lower than
10 %, suggesting that RNA editing in mTECs may followa similar stochastic pattern as promiscuous gene expres-
sion. Moreover, these data imply that accurate assess-
ment of the rate of editing in these sites may require a
higher coverage.
In order to overcome this limitation, we further ex-
plored the global rate of A-to-I RNA editing in mTECs
in comparison to other tissues. For this, we counted the
number of hyper-edited sites in each tissue sample,
using a newly devised pipeline which detects heavily edi-
ted reads [16]. While the normalized number of unique
hyper-edited sites in typical tissues was <3 unique edit-
ing sites per million aligned reads (Fig. 4b), mTEChi cells
demonstrated 4.80 such sites per million aligned reads.
This number is comparable to the number observed in
the brain (4.75) (Fig. 4b), which has been reported to
have the highest RNA-editing capacity from all different
tissues [49]. Notably, cTECs also had a high number of
unique hyper-editing sites but less than the number that
was detected in mTECs (4.15).
Since the number of hyper-edited sites may be affected
by the number of genes expressed in the sample, we also
examined the editing ratio within each sample (i.e. the
ratio of editable sites versus edited sites, see “Methods”).
Similar to the above data, the brain showed the highest
ratio of edited sites (0.44) (Fig. 4c), which was followed by
the mature mTEC (0.31), cTEC (0.29), and Aire-deficient
mTECs (0.27). As in the hyper-editing analysis, the results
obtained for the cTEC sample were similar to mTECs
indicating that the process responsible for the higher ratio
of edited sites in mTECs may occur also in cTECs. These
high RNA-editing levels are probably associated with
Adar1 since its expression levels in mTEChi and cTEC
samples were comparable to the level in the brain tissue,
whereas Adar2 expression levels were significantly higher
in the brain (Additional file 1: Table S3).
In addition, we have performed an additional analysis
in which we examined RNA-editing levels only in sites
that are significantly different between mTECs and the
other individual tissue. In order to overcome biases de-
rived from the different number of reads in the samples,
we used comparable number of reads in each of the
samples (30 M randomly selected reads). Indeed, the
vast majority of statistically significant altered events had
a higher A-to-I editing rate in mTECs vis-à-vis other
tissues, except for mTEClo (Fisher’s exact test, false dis-
covery rate (FDR) ≤ 0.05) (Additional file 1: Table S4).
Next, we examined the level of C-to-U RNA editing,
which is a less prevalent type of RNA-editing mechanism.
The only verified non-synonymous change induced by this
type of editing in mouse is ApoB in which a codon is edited
to a termination codon in mouse liver and small intestine
[24, 25, 50, 51]. Since ApoB is a bona fide TRA gene, which
is expressed by mTECs in an Aire-dependent level, we first
analyzed whether its C-to-U editing is also detectable in
Fig. 4 Higher rate of RNA-editing sites were detected in mTEC cells (A to I). a Heatmap of RNA-editing frequency in known non-synonymous
RNA-editing sites (A to I) edited in at least one of the examined cell types or tissues. Blue rectangle denotes editing site supported by ten reads or
more (edited and non-edited reads), red rectangle denotes editing site supported by less than ten reads, white rectangle denotes no edited reads
were found, black rectangle denotes no reads were found in this editing site. The highest editing level in these non-synonymous sites was found
in the brain. Mature mTECs and AireKO samples have relatively similar editing levels in these sites. b The number of hyper-editing sites in mTECs
is comparable to the brain. The number of unique hyper-editing sites (A to I) per million aligned reads detected in each sample. c Global RNA-
editing rate in mature mTECs is second to the brain and very similar to cTECs. The ratio of edited sites out of all editable sites expressed in each
sample is represented
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level of C-to-U editing of the ApoB transcript in both liver
and mTECs (Fig. 5a).
Moreover, to get a more comprehensive picture, we next
analyzed the level of C-to-U editing at all putative C-to-U
sites that were reported thus far in mouse. Indeed, this ana-
lysis revealed that mTECs display a relatively high C-to-U
RNA-editing frequency compared to other tissues (Fig. 5b).
Specifically, we found that 75 % of colon-specific and liver-
specific editing sites [27, 28] that were covered by reads in
mature mTECs sample were also edited there (Fig. 5b).
Furthermore, although Aire-deficient mTECs displayed less
detectable transcripts undergoing C-to-U editing than
their WT counterparts, the RNA-editing rate for those
that were covered was comparable (Fig. 5b). In con-
trast, mTEClo or cTECs editing rates were much lower
than that obtained for mature mTECs. Moreover,
Apobec1 expression levels were comparable in mTEChi
cells and in the colon and were significantly correlatedto the corresponding C-to-U editing levels (Fig. 5c,
Additional file 1: Table S3). Intriguingly, Apobec1 ex-
pression levels and C-to-U editing levels were very
high in AireKO sample (Fig. 5c), further supporting
that this mechanism is not regulated by Aire.
Discussion
The development of T lymphocytes in the thymus is gov-
erned by two separate lineages of thymic epithelial cells,
the cortical and the medullary, which differ in their ana-
tomical localization and their functional properties [52].
While cTECs control the early steps of T cell develop-
ment, including T lineage commitment, expansion, and
subsequent positive selection of double positive (DP) thy-
mocytes [53], mTECs play a primary role in the later
stages, including negative selection of self-reactive T cells
and generation of thymic regulatory T cells [54, 55].
Crucial to the key role of mTECs in the establishment of
immunological tolerance to self is their unique capacity to
Fig. 5 A high rate of RNA-editing sites are detected in mTEC cells (C to U). a C-to-U editing in ApoB gene in mTECs. Reads coverage in the ApoB C-to-
U editing site (chr12:8014835–8014884), blue denotes the same nucleotide in the genome and in the mapped reads, brown denotes a T nucleotide in
the reads instead of a C in the genome. b C-to-U editing levels in mTECs is comparable to the levels in colon. Heatmap of RNA-editing frequency in 77
sites originally found in the liver and colon edited in at least one of the examined cell types or tissues. Blue rectangle denotes editing site supported by
ten reads or more (edited and non-edited reads), red rectangle denotes editing site supported by less than ten reads, white rectangle denotes no edited
read was found, black rectangle denotes no reads were mapped to this editing site. c High levels of Apobec1 expression in mature mTECs correlate
with high C-to-U editing levels. Correlation of Apobec1 expression levels (DEseq normalized reads count [71]) and editing levels (the number of edited
reads detected in all 77 sites examined out of all reads detected in these sites). AireKO, mTEChi, and colon sample values are specified in the plot
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tissue-restricted antigen genes. Although the physiological
significance of this phenomenon is well-established, the
question to what extent does their transcriptome com-
plexity, which is further expanded by RNA editing and
AS, differs from other tissues in the body has not yet been
addressed in a comprehensive manner. Therefore, tobetter address this important question, we sought to
determine the extent and diversity of promiscuous gene
expression, AS, and RNA editing in this unique cell popu-
lation in comparison to other cell types and tissues.
Indeed, comprehensive RNA-seq analysis validated
that in contrast to all other analyzed cell types and tis-
sues, mature mTECs are capable of expressing the vast
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ically, while most of the tissues express 12,000–14,000
genes (i.e. 60–65 % of the coding genome), the mTEChi
population expresses nearly 18,000 genes, which repre-
sents ~85 % of the coding genome. Interestingly, the
mTEClo population also demonstrated the capacity to
express most of the genome, albeit at very low levels. Such
a low-level promiscuous gene expression may either
suggest that the transcription of most of the genes is initi-
ated (at low levels) already at the stage of immature
mTECs or that the analyzed mTEClo population also con-
tains terminally differentiated mTECs, which have down-
regulated their MHC-II molecules, but still express
residual levels of TRA transcripts. Given that Aire be-
comes expressed only at the mTEChi stage and that the
mTEClo population was indeed found to contain a fraction
of such post-Aire mTECs [56–58], the latter possibility
seems to be more likely. In contrast, the number of genes
expressed by cTECs was found to be similar to that of
other analyzed tissues, suggesting that the phenomenon of
promiscuous gene expression is exclusive only to termin-
ally differentiated mTECs.
Moreover, even in the absence of Aire, the extent of
genome expression in the mTEChi population is higher
(~15 k) than in most of the other analyzed tissues





















Fig. 6 Self-representation in mTECs is expanded by extensive RNA processing.
mTECs. These genes include many of the various tissue specific genes. All are fu
study, we further show very high levels of RNA editing and AS in mTECs. Thesevalidate some of the previous observations suggesting
that a large fraction of TRA genes (i.e. 30–40 %) is
expressed by mTECs in an Aire-independent manner
[59]. The molecular mechanisms controlling the ex-
pression of this Aire-independent fraction, however,
remain elusive.
Importantly, our analysis also reveals that most of
the analyzed peripheral tissues are, to a large extent
(~60–100 %), mirrored in the mTEChi population. The
only exception is the brain and testes, which display
relatively little tissue-specific overlap with mTECs
(55 % and 31 %, respectively). Interestingly, both tis-
sues are considered to be immunologically privileged
sites, which are not under conventional immunological
surveillance. Thus, our data suggest that the stringency
of central tolerance mechanisms to these two immuno-
privileged sites is lower than to other peripheral tissues
with conventional immunological surveillance. Conse-
quently, more brain-reactive and testes-reactive T cell
clones may escape from the thymus to the periphery,
where they must be kept in check by other tolerance
mechanisms, such as antigen sequestering. A good ex-
ample is myelin oligodendrocyte glycoprotein (MOG),
which is not expressed by mTECs, yet it is tolerated by the
immune system, due to its sequestering in the brain. How-
ever, when MOG peptides become exposed (e.g. afterd in mTECs Periphery
mTECs
a Schematic representation of the comprehensive gene expression in the
rther translated into antigens which are represented to T cells. b In this
RNA processes also result in tissue-specific antigens represented in mTECs
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specific T cells, that escaped central tolerance, may become
activated and mount an autoimmune attack on the brain
[60]. Similarly, exposure of testis-specific antigens, e.g. after
testicular injury, can induce a breakdown of self-tolerance
mechanisms and result in autoimmune orchitis [61].
Furthermore, our analysis also revealed that mTECs are
characterized by a high rate of alternatively spliced variants
in comparison to other cell types and tissues (Fig. 6b). This
is in line with a previously published study demonstrating
high entropy of AS products in mTECs [42]. Isoform en-
tropy is a global disorder measurement that typically
increases because of widespread flattened (unbiased) iso-
form expression profiles [62]. Here, based on our analysis,
we further expand this observation by showing that the
high entropy resulted from a high percentage of alterna-
tively spliced genes, a high number of splice variants for
each gene, and a flattened isoform expression profile in
mTECs. A good example to illustrate the ability of mTECs
to generate various tissue-restricted variants is the Src tyro-
sine kinase Fyn, which is highly expressed in two different
alternative forms in the hematopoietic system and in the
brain. Indeed, both isoforms were expressed at comparable
levels in mTECs.
Nevertheless, our results also show that there is a con-
siderable portion of tissue-restricted splice variants that
are not expressed in mTECs. These results therefore
suggest that although mTECs demonstrate a dramatic-
ally higher rate of AS than other tissues, it seems to be
less robust and comprehensive than their promiscuous
gene expression capacity. This observation may be partly
explained by the stochastic nature of the splicing ma-
chinery which gives rise to splice variants that probably
represent “noise” [63, 64]. Still, the results imply that
there is a relatively high probability for splice isoforms
that are being expressed in peripheral tissues and not in
the thymus, which may then increase susceptibility to
autoimmunity, as was suggested for the PLP gene [30].
Our data suggest that Aire, which induces expression
of many tissue-restricted antigen genes, does not seem
to have a direct role in increasing the variety of tissue-
restricted RNA-splicing products. Recently, it has been
suggested that Aire regulates the inclusion of thousands
of exons [39, 42]. However, our analyses imply minor
changes in AS between AireKO and WT mTECs. Specific-
ally, we observed significant differences in the expression
of testes-specific and kidney-specific splice variants be-
tween the AireKO and WT mTECs and the lower overall
rate of alternatively spliced genes in the Aire-deficient
sample. Nevertheless, unlike the results obtained for
whole gene expression, the differences between the cover-
age of most TRA variants generated by AS were similar
between AireKO and WT mTECs. Hence, we suggest that
Aire might have an indirect effect on the AS rate (e.g.through differential expression of specific splicing factors
in AireKO mTECs).
We also found, for the first time, a high RNA-editing
level (A-to-I and C-to-U) in mature mTECs (Fig. 6b).
Global A-to-I and C-to-U RNA-editing levels in mature
mTECs were comparable to the levels in the brain and
colon, respectively, which are known to have the highest
RNA-editing levels to date [27, 28, 49]. The high rate of
RNA editing in mature mTECs detected here suggests
that at some level most of the sites that have non-
synonymous effect on the resulted protein are edited
and hence presented to the T cells. It should be noted
that many of the A-to-I sites examined here were ori-
ginally found to be edited only in the brain, thus our
A-to-I analyses may include a high number of brain-
specific editing sites. Our C-to-U editing results re-
vealed, for the first time, C-to-U editing in mTECs in a
bona fide Aire-dependent TRA gene—ApoB—whose
expression is restricted only to the liver and small in-
testine of mice [24, 25, 50, 51].
A high capacity of RNA editing was observed in Aire-
deficient mTECs, but not in immature mTECs. Thus, an-
other regulator (or regulators) probably mediates high
RNA processing, specifically in mature mTECs. Moreover,
it is reasonable that similar A-to-I editing regulation (but
not C-to-U) probably occurs in cTECs.Conclusions
The high transcriptome complexity and high rate of
RNA-processing TRAs we found to be expressed in
mature mTECs ensure lower rate of differences of
antigens between mTECs and any peripheral tissue.
Specifically, our results demonstrate a high level of
two types of RNA editing, A-to-I and C-to-U editing,
together with a high rate and diversity of AS in mTECs.
Moreover, our results suggest a limited role of Aire in the
regulation of this high variability. Thus, our study high-
lights another layer by which mTECs expand the already
broad repertoire of self-representation, which is required
for the establishment of self-tolerance and prevention of
autoimmunity.Methods
RNA-seq library preparation
The AireKO population was isolated from individual
strains (wild-type B6) with a FACSAria III cell sorter
(BD), RNA was extracted and sequenced as detailed be-
fore [65]. Briefly, poly-A-selected transcriptome librar-
ies were generated with a TruSeq V3 RNA Sample Prep
according to the manufacturer’s protocols (Illumina).
Paired-end (2 × 100 bp) sequencing was performed with
an Illumina HiSeq2000 machine.
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We used RNA-seq data from 13 different cell or tissue
types. Details and sample sources are provided in Additional
file 1: Table S1. STAR aligner (version 2.3.0) [66] was used
to align each RNA-seq read uniquely to the mm9 mouse
genome (default parameters).
Data analysis
The statistical analysis was done using R (the R Project
for Statistical Computing (http://www.r-project.org/)).
Expression and leave-one-out analyses
To compare global mTEC gene expression to other tis-
sues, we created comparable samples by selection of 10,
20, 30, 40, and 50 million random aligned reads from each
sample. The number of reads aligned to UCSC known
genes track was counted using featureCounts [67] (param-
eters: −b -f –O –p). These counts were normalized by
dividing the counts per gene by the gene length.
To assess TRA gene expression by mTECS, whole sam-
ple FPKM values were compared. FPKM was calculated
using RSEM [68] for each RNA-seq sample. If not men-
tioned otherwise, a gene was considered as expressed if its
FPKM value was > 0.3. A TRA gene was defined as gene
that was highly expressed (FPKM> 5) in one of the tissues
examined and was either lowly (FPKM< 0.3) or not
expressed in other tissues.
In order to compare TRA expression in mTECs versus
other tissues, leave-one-out procedure was obtained on
comparable size RNA-seq samples (30 million randomly
selected aligned reads). The procedure was performed by
first excluding a given i-th sample, finding genes that are
expressed uniquely in each sample (and not in the other
remaining tissues), and then assessing the ratio of these
genes expressed in the i-th sample. A gene was considered
expressed if the normalized read counts was > 0.01.
Alternative splicing analysis
To determine AS frequency differences between the ex-
amined tissue and cell types, we used STAR splice junc-
tions output file. In order to obtain comparable samples,
reads longer than 80 nt were trimmed and 50 million
random reads were selected from each sample. For each
coding gene expressed in the tissue, we inferred whether
it was alternatively spliced by finding at least two splice
junctions that either start or end at the same position.
We also compared the number of all the junctions de-
tected within each gene expressed both in mTECs and
each of the other tissues examined. Comparison of alter-
natively spliced variants was also conducted using
rMATs [44]. The number of significantly altered exons
in which one form was expressed in the examined tissue
and two in mTECs and vice versa was compared.The TRA junction was defined as a junction that is
supported by at least ten reads in a specific tissue and not
in any of the other tissues examined (mTECs excluded)
and is found inside a gene that was expressed in at least
additional tissue. In order to assess the extent of TRAs
that result from tissue-restricted AS, we calculated the ra-
tio of TRA junctions of each of the tissues examined
expressed in mTECs and AireKO samples out of the TRA
junctions expressed in the tissue. The same ratio was
calculated for splice junctions of known events (Cassette
exons, alternative 3’ splice site, and alternative 5’ splice
site) from the AltEvents track of the UCSC genome
browser [46].RNA-editing analysis
To evaluate the global extent of RNA editing (A-to-I)
in mTECs versus other cell types, we estimated the
extent of hyper-editing, the editing rate of each RNA-
seq sample, and compared the number of sites signifi-
cantly altered between mTECs and other cell types.
Hyper-edited sites were identified as described in [16]
using the reads that did not align to the genome at first
(same parameters except read length > 80 % of total
number of mismatches requirement instead 60 %). For
each sample, the number of unique hyper-editing sites
was normalized by the number of mapped reads.
The editing rate was computed as the percentage of
editing sites in which the edited variant was expressed
out of all known editable sites expressed in a given
tissue. We randomly sampled 30 million aligned reads
from each RNA-seq for comparable sample size. RNA-
editing levels were calculated using the REDItool-
Known.py script that is part of REDItools package [69].
Mouse A-to-I editing site annotations were down-
loaded from the RADAR database ([18], v1 including
8109 sites) and were also inferred from the hyper-
editing results (total of 22,701 sites). For C-to-U edit-
ing, site annotations were taken from [27, 28]. The
editing level was computed as the percentage of the
edited reads out of all reads mapped to known editable
sites expressed in a given tissue. We also compared the
number of editing sites significantly altered between
sites expressed both in mTECs and each of the other
tissues examined using Fisher’s exact test with correc-
tion to multiple testing (FDR). The same methods were
used in order to evaluate the editing rate in sites with
non-synonymous effect on the protein. Coding and
protein effect information was obtained from Annovar
[70]. For this analysis we used all the reads in each
sample.
Adar1, Adar2, and Apobec1 normalized reads counts
were calculated using DEseq [71]. Mapping visualization
was performed using Savant genome browser [72].
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